Investors just got three extra weeks to decide if they need to care about tariffs again. But Wall Street's tariff optimism could be tested if President Trump picks tougher trade negotiation tactics ...

OPEC+ is expected to fully unwind its 2.2 million bpd output cuts by September, following a surprise superhike in August.

South African stocks are poised to extend their rally in the second half, buoyed by an improving outlook for the domestic ...

Goldman Sachs anticipates that a group of eight OPEC+ member countries will raise their oil production quotas by 550,000 ...

Stock futures pointed to a lower open Monday as Trump said he'd start sending out letters outlining tariff rates to countries around the world. The president also took to social media and threatened ...

Apollo, for one, expects just one rate cut in 2025. JPMorgan strategists forecast two. Goldman Sachs last week updated its ...

Goldman Sachs commodity analysts are sticking to their forecast for Brent to average $59 a barrel by the fourth quarter of this year and $56 in 2026, following a bigger-than-expected production rise ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

European natural-gas prices slipped as markets braced for U.S. tariffs. EU storage levels were currently 60% full. Gold futures slipped on a stronger dollar though they remain up more than 25% year to ...

Glissmann, asset allocation research head at Goldman Sachs, discusses markets in the lead up to the July 9 deadline to negotiate trade deals with the US. "I think there's been a bit too much ...

A lot has been said about the emerging technology's world-changing potential: Its ability to create stunningly realistic ...

Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...